Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Guyana Goldfields Proposes Offering Of C$8.4 Mln Share At C$2.91/shr

Guyana Goldfields Inc. (GUY.TO: Quote) said Wednesday that it proposes to issue 8,391,069 common shares at a price of C$2.91 per share in a non-brokered private placement. The company expects aggregate gross proceeds of about C$24,418,010 from the placement.

The offering is scheduled to close on or about April 24, and is subject to a number of conditions, including, without limitation, receipt of all regulatory approvals, including the approval of the Toronto Stock Exchange, and completion of definitive documentation. The shares issued upon the closing of the private placement will be subject to a 4-month hold period.

The company said it will use the net proceeds from the offering towards the strategic plans for 2012 and to continue exploration of its portfolio of gold exploration properties in Guyana.

The Baupost Group, L.L.C., a Boston, Massachusetts based institutional investor, has agreed to purchase 7,891,069 of the common shares for C$22,963,010. Upon closing of the placement, Baupost will hold approximately 18.3 percent of the company's shares and will have the right to appoint an independent director to the board of directors of Guyana Goldfields.

The company's Chief Executive Officer and Interim President, Chief Operating Officer Patrick Sheridan has agreed to purchase 500,000 of the shares for C$1,455,000.

Guyana Goldfields has initiated a revised Feasibilty Study for the Aurora Gold Project which has the potential to improve the economics of the project. The revised Feasibility Study, which will investigate oppurtunities in the underground, open pit, civil works, processing and economics, is expected to complete in the fourth-quarter.

Register
To receive FREE breaking news email alerts for Guyana Goldfields J and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.